Advertisement
Screener

Milestone Pharmaceuticals Inc. (MIST) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Milestone Pharmaceuticals Inc. Cash Flow Breakdown

Cash flow breakdown shows where Milestone Pharmaceuticals Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $49.04M went out.
  • Fiscal year ended 2025-12-31: from investing, $11.25M came in.
  • Fiscal year ended 2025-12-31: from financing, $85.53M came in.
  • Fiscal year ended 2025-12-31: change in cash, $47.73M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$49.04M$11.25M$37.59M$47.93M*$47.73M
2024-12-31-$28.85M$8.28M$27.26M$4.86M*$11.55M
2023-12-31-$46.42M$4.76M$189.00K$47.60M*$6.12M
2022-12-31-$52.47M-$57.12M$2.63M-$106.50M
2021-12-31-$33.22M$70.00M$121.00K$4.93M*$41.83M
2020-12-31-$50.73M-$70.00M$24.92M$48.31M*-$47.51M
2019-12-31-$51.15M-$384.00K$44.00K$85.36M*$33.87M
2018-12-31-$21.05M$16.00M$461.00K$79.65M*$75.07M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$22.71M*$111.99M*$0.00*$9.13M*
2026-03-31-$16.05M-$80.03M$10.89M$83.46M*-$1.73M
2025-12-31-$12.78M*$2.70M*$14.45M*$21.98M*
2025-09-30-$9.75M*-$34.98M*$122.00K*$48.80M*
2025-06-30-$12.57M*$9.94M*
2025-03-31-$13.95M$33.58M$19.77M
2024-12-31-$6.84M*$19.33M*$0.00*
2024-09-30-$7.02M*$6.48M*$0.00*
2024-06-30-$6.05M*$9.48M*-$280.00K*
2024-03-31-$8.93M-$27.01M$27.54M$4.78M*-$3.63M
2023-12-31-$9.80M*$13.68M*$1.00K*
2023-09-30-$12.16M*-$10.86M*$40.00K*
2023-06-30-$10.56M*-$28.03M*$24.00K*-$2.79M*
2023-03-31-$13.90M$29.97M$124.00K$50.13M*$66.32M
2022-12-31-$12.86M*-$17.02M*-$14.00K*
2022-09-30-$11.57M*-$17.05M*$28.00K*$2.64M*
2022-06-30-$14.09M*-$15.06M*$140.00K*
2022-03-31-$13.95M-$8.00M$49.00K-$21.90M
2021-12-31-$12.38M*$15.00M*$78.00K*
2021-09-30-$9.39M*$23.00M*$24.00K*
2021-06-30$1.01M*$20.00M*$0.00*$4.92M*
2021-03-31-$12.47M$12.00M$19.00K-$451.00K
2020-12-31-$8.76M*-$14.00M*$3.00K*$48.15M*
2020-09-30-$7.33M*-$24.00M*$48.00K*$24.77M*
2020-06-30-$16.56M*$172.00K*
2020-03-31-$18.08M$77.00K-$18.00M
2019-12-31-$16.60M*$29.90M*$19.00K*
2019-09-30-$8.30M*$4.71M*$0.00*-$731.00K*
2019-06-30-$11.52M*$0.00*$86.09M*
2019-03-31-$14.73M$25.00K-$14.71M
2018-12-31-$7.31M*$8.98M*$424.00K*$79.65M*
2018-09-30-$5.59M*-$8.02M*$0.00*
2018-06-30-$3.42M*$8.03M*$7.00K*
2018-03-31-$4.72M$7.00M$30.00K$2.30M

Similar stocks

Stock NameCountryMarket CapPE Ratio
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Anixa Biosciences Inc (ANIX)United States$0.096B
ProMIS Neurosciences Inc. (PMN)$0.102B
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Rallybio Corp (RLYB)United States$0.089B
Equillium, Inc. (EQ)United States$0.109B-11.27
GENELUX Corp (GNLX)United States$0.110B-3.83
ONCOLYTICS BIOTECH INC (ONCY)$0.086B